Andros Day Surgery Clinic Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2013
NCT01816789
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

follitropin alfa (1 trial)

progesterone (progestasert) (1 trial)

receptal (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3